Search research articles
Contact Us
Filters
Showing results (1-10 of 208) with videos related to
Page
of 21
Sort By:
Lakartidningen
|
January 11, 2007
[About mice and men. Not certain that findings in mice with Alzheimer disease can be applied in clinical reality]
Lennart Minthon
Clinical Interventions in Aging
|
December 9, 2014
Solitary living in Alzheimer's disease over 3 years: association between cognitive and functional impairment and community-based services
Carina Wattmo, Elisabet Londos, Lennart Minthon
Dementia and Geriatric Cognitive Disorders
|
September 4, 2015
Longitudinal Associations between Survival in Alzheimer's Disease and Cholinesterase Inhibitor Use, Progression, and Community-Based Services
Carina Wattmo, Elisabet Londos, Lennart Minthon
BMC Neurology
|
September 13, 2014
Response to cholinesterase inhibitors affects lifespan in Alzheimer's disease
Carina Wattmo, Elisabet Londos, Lennart Minthon
BMC Neurology
|
September 2, 2016
Cholinesterase inhibitors do not alter the length of stay in nursing homes among patients with Alzheimer's disease: a prospective, observational study of factors affecting survival time from admission to death
Carina Wattmo, Elisabet Londos, Lennart Minthon
Lakartidningen
|
December 25, 2013
[Modern dementia care on the rise thanks to national guidelines]
Katarina Nägga, Lennart Minthon, Maria Eriksdotter
Current Alzheimer Research
|
May 8, 2018
Short-Term Response to Cholinesterase Inhibitors in Alzheimer's Disease Delays Time to Nursing Home Placement
Carina Wattmo, Elisabet Londos, Lennart Minthon
Dementia and Geriatric Cognitive Disorders
|
July 5, 2014
Risk factors that affect life expectancy in Alzheimer's disease: a 15-year follow-up
Carina Wattmo, Elisabet Londos, Lennart Minthon
Alzheimer'S Research & Therapy
|
February 18, 2016
Mild versus moderate stages of Alzheimer's disease: three-year outcomes in a routine clinical setting of cholinesterase inhibitor therapy
Carina Wattmo, Lennart Minthon, Åsa K Wallin
BMC Neurology
|
November 7, 2012
Functional response to cholinesterase inhibitor therapy in a naturalistic Alzheimer's disease cohort
Carina Wattmo, Asa K Wallin, Lennart Minthon
Page
of 21
Search research articles
Search
Showing results (1-10 of 208) with videos related to
Sort By:
Page
of 21
Lakartidningen
|
January 11, 2007
[About mice and men. Not certain that findings in mice with Alzheimer disease can be applied in clinical reality]
Lennart Minthon
Clinical Interventions in Aging
|
December 9, 2014
Solitary living in Alzheimer's disease over 3 years: association between cognitive and functional impairment and community-based services
Carina Wattmo, Elisabet Londos, Lennart Minthon
Dementia and Geriatric Cognitive Disorders
|
September 4, 2015
Longitudinal Associations between Survival in Alzheimer's Disease and Cholinesterase Inhibitor Use, Progression, and Community-Based Services
Carina Wattmo, Elisabet Londos, Lennart Minthon
BMC Neurology
|
September 13, 2014
Response to cholinesterase inhibitors affects lifespan in Alzheimer's disease
Carina Wattmo, Elisabet Londos, Lennart Minthon
BMC Neurology
|
September 2, 2016
Cholinesterase inhibitors do not alter the length of stay in nursing homes among patients with Alzheimer's disease: a prospective, observational study of factors affecting survival time from admission to death
Carina Wattmo, Elisabet Londos, Lennart Minthon
Lakartidningen
|
December 25, 2013
[Modern dementia care on the rise thanks to national guidelines]
Katarina Nägga, Lennart Minthon, Maria Eriksdotter
Current Alzheimer Research
|
May 8, 2018
Short-Term Response to Cholinesterase Inhibitors in Alzheimer's Disease Delays Time to Nursing Home Placement
Carina Wattmo, Elisabet Londos, Lennart Minthon
Dementia and Geriatric Cognitive Disorders
|
July 5, 2014
Risk factors that affect life expectancy in Alzheimer's disease: a 15-year follow-up
Carina Wattmo, Elisabet Londos, Lennart Minthon
Alzheimer'S Research & Therapy
|
February 18, 2016
Mild versus moderate stages of Alzheimer's disease: three-year outcomes in a routine clinical setting of cholinesterase inhibitor therapy
Carina Wattmo, Lennart Minthon, Åsa K Wallin
BMC Neurology
|
November 7, 2012
Functional response to cholinesterase inhibitor therapy in a naturalistic Alzheimer's disease cohort
Carina Wattmo, Asa K Wallin, Lennart Minthon
Page
of 21